Security Snapshot

GLOBUS MEDICAL INC - Class A Stock (GMED) Institutional Ownership

CUSIP: 379577208

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

555

Shares (Excl. Options)

111,055,341

Price

$87.31

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Class A Stock
Symbol
GMED on NYSE
Shares outstanding
115,244,363
Price per share
$86.16
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
111,055,341
Total reported value
$9,704,159,812
% of total 13F portfolios
0.02%
Share change
+48,750
Value change
+$149,786,841
Number of holders
555
Price from insider filings
$86.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • GMED - GLOBUS MEDICAL INC - Class A Stock is tracked under CUSIP 379577208.
  • 555 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 555 to 74 between Q4 2025 and Q1 2026.
  • Reported value moved from $9,704,159,812 to $231,647,295.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 555 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of GLOBUS MEDICAL INC - Class A Stock (GMED) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.1% +16% $778,991,964 -$11,095,352 10,487,237 -1.4% BlackRock, Inc. 31 Mar 2025
JANUS HENDERSON GROUP PLC 6.1% +5% $522,135,958 +$30,787,723 7,029,294 +6.3% JANUS HENDERSON GROUP PLC 31 Mar 2025

As of 31 Dec 2025, 555 institutional investors reported holding 111,055,341 shares of GLOBUS MEDICAL INC - Class A Stock (GMED). This represents 96% of the company’s total 115,244,363 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of GLOBUS MEDICAL INC - Class A Stock (GMED) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.2% 10,549,455 -0.53% 0.01% $921,072,916
BlackRock, Inc. 8.9% 10,284,093 -2.4% 0.02% $897,904,166
JANUS HENDERSON GROUP PLC 6.3% 7,294,878 -3.4% 0.29% $636,916,203
Invesco Ltd. 3.4% 3,886,405 +1235% 0.05% $339,322,022
STATE STREET CORP 3% 3,463,845 +0.06% 0.01% $302,428,307
BANK OF MONTREAL /CAN/ 2.9% 3,373,260 +15317% 0.12% $294,519,330
JPMORGAN CHASE & CO 2.7% 3,098,773 -16% 0.02% $270,553,943
Sculptor Capital LP 2.6% 3,000,000 -14% 3.2% $261,930,000
Madison Avenue Partners, LP 2.3% 2,624,751 +3% 9.8% $229,167,010
CITADEL ADVISORS LLC 2.2% 2,539,396 +2165% 0.15% $221,714,665
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.2% 2,519,782 -11% 0.61% $220,002,166
GEODE CAPITAL MANAGEMENT, LLC 1.8% 2,056,774 -0.3% 0.01% $179,614,258
GENEVA CAPITAL MANAGEMENT LLC 1.7% 1,901,974 -8.7% 3.1% $166,061,363
ALLIANCEBERNSTEIN L.P. 1.6% 1,844,958 -10% 0.05% $161,083,283
DIMENSIONAL FUND ADVISORS LP 1.5% 1,735,921 -14% 0.03% $151,567,419
GW&K Investment Management, LLC 1.3% 1,516,345 -15% 1.1% $132,392,000
Boston Trust Walden Corp 1.2% 1,367,987 +15% 0.9% $119,438,945
Vestal Point Capital, LP 1.1% 1,275,000 +2% 4.1% $111,320,250
Parsifal Capital Management, LP 1.1% 1,222,717 +11% 11% $106,755,421
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,190,617 -1.1% 0.02% $103,952,770
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.96% 1,105,606 +129818% 0.12% $103,475,000
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.96% 1,101,866 -14% 0.08% $96,203,920
FULLER & THALER ASSET MANAGEMENT, INC. 0.9% 1,035,518 0.31% $90,411,073
NORGES BANK 0.89% 1,029,913 0.01% $89,921,704
MARSHALL WACE, LLP 0.85% 975,896 -43% 0.08% $85,205,481

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,698,697 $231,647,295 +$40,781,474 $86.16 74
2025 Q4 111,055,341 $9,704,159,812 +$149,786,841 $87.31 555
2025 Q3 115,933,964 $6,654,707,679 +$72,456,317 $57.27 488
2025 Q2 114,075,801 $6,730,550,265 +$195,769,879 $59.02 477
2025 Q1 109,345,858 $7,997,914,722 -$8,993,495 $73.20 507
2024 Q4 108,904,887 $9,007,980,911 +$44,310,752 $82.71 495
2024 Q3 108,072,594 $7,734,964,942 -$332,078,125 $71.54 444
2024 Q2 112,764,178 $7,722,959,830 -$3,143,182 $68.49 443
2024 Q1 113,402,229 $6,082,679,016 +$359,376,321 $53.64 435
2023 Q4 106,692,854 $5,685,431,048 -$155,605,070 $53.29 405
2023 Q3 109,414,808 $5,433,176,387 +$1,362,204,600 $49.65 426
2023 Q2 81,374,906 $4,843,899,307 +$408,515,363 $59.54 378
2023 Q1 74,600,238 $4,224,726,594 -$151,471,403 $56.64 381
2022 Q4 75,948,098 $5,639,196,814 +$86,702,611 $74.27 383
2022 Q3 74,451,382 $4,436,437,568 +$100,448,577 $59.57 356
2022 Q2 72,222,203 $4,054,750,490 +$112,004,727 $56.14 349
2022 Q1 69,530,797 $5,130,106,470 +$81,009,114 $73.78 366
2021 Q4 68,345,177 $4,935,105,853 +$7,508,095 $72.20 367
2021 Q3 67,700,811 $5,190,187,299 -$70,035,321 $76.62 380
2021 Q2 68,045,932 $5,276,020,366 +$27,082,820 $77.53 351
2021 Q1 67,739,467 $4,178,223,997 +$52,788,626 $61.67 338
2020 Q4 66,616,139 $4,344,582,646 +$137,526,882 $65.22 343
2020 Q3 64,418,606 $3,189,910,125 -$115,537,152 $49.52 336
2020 Q2 66,705,847 $3,180,329,751 -$236,172,306 $47.71 312
2020 Q1 71,806,963 $3,053,523,816 +$121,157,476 $42.53 266
2019 Q4 67,279,881 $3,960,808,169 -$28,832,985 $58.88 304
2019 Q3 68,078,022 $3,478,746,497 +$23,175,292 $51.12 266
2019 Q2 67,934,676 $2,873,736,931 +$68,262,206 $42.30 255
2019 Q1 66,704,822 $3,293,778,190 -$65,694,730 $49.41 264
2018 Q4 68,249,962 $2,953,271,922 +$98,486,796 $43.28 301
2018 Q3 65,487,760 $3,715,590,483 +$107,199,480 $56.76 310
2018 Q2 63,650,675 $3,211,939,865 +$91,311,533 $50.46 285
2018 Q1 61,964,717 $3,079,267,072 -$55,501,163 $49.82 276
2017 Q4 63,316,479 $2,600,052,259 -$177,983,391 $41.10 254
2017 Q3 68,779,684 $2,044,301,959 +$133,468,390 $29.72 247
2017 Q2 63,912,936 $2,113,531,840 -$6,742,413 $33.15 240
2017 Q1 66,448,625 $1,968,206,890 +$212,215,068 $29.62 240
2016 Q4 66,416,082 $1,647,898,444 +$49,757,687 $24.81 204
2016 Q3 65,110,721 $1,468,682,032 -$90,108,711 $22.57 191
2016 Q2 68,944,209 $1,642,903,804 +$5,899,417 $23.83 203
2016 Q1 69,470,642 $1,648,818,412 +$41,022,318 $23.75 200
2015 Q4 66,193,785 $1,841,465,465 +$9,162,505 $27.82 185
2015 Q3 66,646,506 $1,376,939,977 +$85,476,007 $20.66 178
2015 Q2 62,535,892 $1,605,270,230 -$1,848,789 $25.67 177
2015 Q1 62,724,615 $1,582,790,729 +$33,704,934 $25.24 178
2014 Q4 61,313,895 $1,457,510,086 +$92,436,342 $23.77 181
2014 Q3 57,176,622 $1,124,529,205 +$35,352,082 $19.67 163
2014 Q2 54,426,902 $1,301,914,540 +$4,051,848 $23.92 174
2014 Q1 53,176,394 $1,411,676,236 +$60,435,010 $26.59 157